News

Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs

Partnership enhances CBM’s manufacturing capabilities in C&GT space

Agreement allows CRO to grow its manufacturing services, including in the chemistry space

November report indicates a decrease in air cargo compared to October, but a rise in global demand compared to pre-Covid numbers

Syneos Health’s annual survey reveals the potential for shifts in the M&A space

Marks the first step in two-phase facility expansion project

Center’s 89,000 square-foot expansion expected to double its capacity

Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies

Collaboration aims to prioritize best practices in fields of biopreservation and closed-system manufacturing, while improving children’s health

The shot—which could be the first one to be mRNA based—is scheduled to begin clinical trials later this year

Development project features 150,000 square feet of additional space to accommodate company’s 3PL offerings

Investment features the construction of a high-throughput screening center

BFS technology deal expected to be finalized in Q1

Ruling also shortens time required between the initial two shots and the booster to five months

Deal expands GE’s $3 billion ultrasound business from diagnostics into surgical and therapeutic interventions

Emergency-use clearance of Pfizer drug a major milestone in the fight against the now-omicron-fueled virus in the US

The latest people news happenings over the past month

The new parent company will expand security, monitoring and remedial action for pharma shipments

Parties will collaborate in enhancing chronic disease care therapies

Firms will merge under the CSafe brand, allowing for delivery of temperature-sensitive items

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Purchase of Engage grows the company’s knowledge in the data and analytics space

Pharma firms—not only in Europe but in the US as well—are continuously looking for alternative supply channels inside their respective blocks

Deal expands pharma giant’s influence in inflammation and immunology markets

Includes 20 million more doses by the end of the 2021

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Via investment partnership with Taishin Holdings, will begin offering manufacturing services in C&GT space

Survey draws attention to the need for improving issues surrounding supply chain visibility